Association of the functional polymorphism in the catechol-O-methyltransferase gene with schizophrenia in the three ethnic groups of the Malaysian population

Psychiatry Research

Volumn 189, Issue 1, 2011, Pages 67-71

  Wan, Ching Lee ^a   Zainal, Nor Zuraida ^a   Lian, Lay Hoong ^a   Mohamed, Zahurin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Chinese; COMT; Indian; Malay; Val158Met

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CHINESE; COMT GENE; CONTROLLED STUDY; ETHNIC GROUP; ETHNICITY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAYSIAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80051684108     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.02.008     Document Type: Article

References (47)

1. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., Jones P.B. Gender-specific effects of the catechol-O-methyltransferase Val(108)/(158)Met polymorphism on cognitive function in children. The American Journal of Psychiatry 2007, 164:142-149.
2. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29:1943-1961.
3. Boudikova B., Szumlanski C., Maidak B., Weinshilboum R. Human liver catechol-O-methyltransferase pharmacogenetics. Clinical Pharmacology and Therapeutics 1990, 48:381-389.
4. Bray N.J., Buckland P.R., Williams N.M., Williams H.J., Norton N., Owen M.J., O'Donovan M.C. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. American Journal of Human Genetics 2003, 73:152-161.
5. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988, 1:179-186.
6. Coman I.L., Gnirke M.H., Middleton F.A., Antshel K.M., Fremont W., Higgins A.M., Shprintzen R.J., Kates W.R. The effects of gender and catechol O-methyltransferase (COMT) Val108/158Met polymorphism on emotion regulation in velo-cardio-facial syndrome: an fMRI study. Neuroimage. 2010, 10.1016/j.neuroimage.2010.01.094.
7. Costas J., Sanjuán J., Ramos-Ríos R., Paz E., Agra S., Ivorra J.L., Páramo M., Brenlla J., Arrojo M. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. Journal of Psychiatric Research 2010, 10.1016/j.jpsychires.2010.04.021.
8. Daniels J.K., Williams N.M., Williams J., Jones L.A., Cardno A.G., Murphy K.C., Spurlock G., Riley B., Scambler P., Asherson P., McGuffin P., Owen M.J. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. The American Journal of Psychiatry 1996, 153:268-270.
9. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. PNAS 2001, 98(12):6917-6922.
10. Fan J.B., Chen W.Y., Tang J.X., Li S., Gu N.F., Feng G.Y., Breen G., St Clair D., He L. Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Molecular Psychiatry 2002, 7:446-447.
11. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., Feng G.Y., St Clair D., He L. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biological Psychiatry 2005, 57:139-144.
12. Faul F., Erdfelder E. GPOWER: A Priori, Post-hoc, and Compromise Power Analyses for MS-DOC [Computer Program] 1992, Bonn University, Department of Psychology, Bonn, FRG.
13. Funke B., Malhotra A.K., Finn C.T., Plocik A.M., Lake S.L., Lencz T., DeRosse P., Kane J.M., Kucherlapati R. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behavioral and Brain Functions 2005, 1:19.
14. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. The American Journal of Psychiatry 2003, 160:469-476.
15. Goghari V.M., Sponheim S.R. Divergent backward masking performance in schizophrenia and bipolar disorder: association with COMT. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2008, 147B(2):223-227.
16. Handoko H.Y., Nyholt D.R., Hayward N.K., Nertney D.A., Hannah D.E., Windus L.C., McCormack C.M., Smith H.J., Filippich C., James M.R., Mowry B.J. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Molecular Psychiatry 2005, 10:589-597.
17. Hoenicka J., Garrido E., Martínez I., Ponce G., Aragüés M., Rodríguez-Jiménez R., España-Serrano L., Alvira-Botero X., Santos J.L., Rubio G., Jiménez-Arriero M.Á., Palomo T. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. American Journal of Medical Genetics Part B 2010, 153B:79-85. PARG.
18. Honea R., Verchinski B.A., Pezawas L., Kolachana B.S., Callicott J.H., Mattay1 V.S., Weinberger D.R., Meyer-Lindenberg A. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 2009, 45(1):44-51.
19. Illi A., Kampman O., Anttila S., Roivas M., Mattila K.M., Lehtimaki T., Leinonen E. Interaction between angiotensin-converting enzyme and catechol-Omethyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. European Neuropsychopharmacology 2003, 13:147-151.
20. Joo E.J., Jeong S.H., Ahn Y.M., Lee K.Y., Yoon S.C., Kim E.J., Kim S.U., Cho S.C., Kim Y.S. No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies. Psychiatry Research 2005, 136:83-91.
21. Kotler M., Barak P., Cohen H., Averbuch I.E., Grinshpoon A., Gritsenko I., Nemanov L., Ebstein R.P. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. American Journal of Medical Genetics 1999, 88:628-633.
22. Kremer I., Pinto M., Murad I., Muhaheed M., Bannoura I., Muller D.J., Schulze T.G., Reshef A., Blanaru M., Gathas S., Goichman R., Rietschel M., Dobrusin M., Bachner-Melman R., Nemanov L., Belmaker R.H., Maier W., Ebstein R.P. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. American Journal of Medical Genetics Part B 2003, 119B(1):35-39.
23. Lafuente A., Bernardo M., Mas S., Crescenti A., Aparici M., Gasso P., Deulofeu R., Mane A., Catalan R., Carne X. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and -141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders. Psychiatry Research 2008, 161:131-141.
24. Lee S.G., Joo Y., Kim B., Chung S., Kim H.L., Lee I., Choi B., Kim C., Song K. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Human Genetics 2005, 116:319-328.
25. Li T., Ball D., Zhao J., Murray R.M., Liu X., Sham P.C., Collier D.A. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Molecular Psychiatry 2000, 5:452.
26. Liu C.H., Ho K.L., Hou K.C., Lai K.F. A New History of Malaysian Chinese, 3 Volume (in Chinese) 1998, The Federation of Chinese Association Malaysia, Kuala Lumpur.
27. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Malén K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of thermolabile variant of enzyme. Biochemistry 1995, 34:4202-4210.
28. Mata I., Perez-Iglesias R., Pelayo-Teran J.M., Rodríguez-Sanchez J.M., Gonzalez-Blanch C., Carrasco-Marin E., Vazquez-Barquero J.L., Crespo-Facorro B. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis. Schizophrenia Research 2008, 102:206-209.
29. Munafò M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Molecular Psychiatry 2005, 10:765-770.
30. Nunokawa A., Watanabe Y., Muratake T., Kaneko N., Koizumi M., Someya T. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neuroscience Research 2007, 58:291-296.
31. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N., Iwata N. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophrenia Research 2009, 110:140-148.
32. Pal P., Mihanović M., Molnar S., Xi H., Sun G., Guha S., Jeran N., Tomljenović A., Malnar A., Missoni S., Deka R., Rudan P. Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population. Croatian Medical Journal 2009, 50:361-369.
33. Pulver A.E., Karayiorgou M., Wolyniec P.S., Lasseter V.K., Kasch L., Nestadt G., Antonarakis S., Housman D., Kazazian H.H., Meyers D., Ott J., Lamacz M., Liang K.Y., Hanfelt J., Ullrich G., DeMarchi N., Ramu E., McHugh P.R., Adler L., Thomas M., Carpenter M.T., Manschreck T., Gordon C.T., Kimberland M., Babb R., Puck J., Childs B. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. American Journal of Medical Genetics 1994, 54:36-43.
34. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martinez-Larrea A., Fañanás L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. The American Journal of Psychiatry 2004, 161(6):1110-1112.
35. Sainuddin S. Titas tamadun Melayu (Malay civilization Titas) 2003, Quantum Books, Perak.
36. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Molecular Brain Research 2004, 132:51-56.
37. Semwal P., Prasad S., Bhatia T., Deshpande S.N., Wood J., Nimgaonkar V.L., Thelma B.K. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Molecular Psychiatry 2001, 6:220-224.
38. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research 2005, 15(2):97-98.
39. Shifman S., Bronstein M., Sternfeld M., Pisanté A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics 2002, 71:1296-1302.
40. Sindhu K.S. The coming of the Indians to Malaysia. Indian Communities in South East Asia 1993, 151-189. ISEAS Publishing, Singapore. K.S. Sindhu, A. Mani (Eds.).
41. Strous R.D., Bark N., Parsia S.S., Volavka J., Lachman H.M. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Research 1997, 69:71-77.
42. Üçok A., Öztürk M., Duman Z., Saruhan-Direskeneli G. COMT Val158Met polymorphism is related with interpersonal problem solving in schizophrenia. European Psychiatry 2010, 10.1016/j.eurpsy.2010.01.012.
43. Volavka J., Kennedy J.L., Ni X., Czobor P., Nolan K., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J., Lieberman J.A. COMT158 polymorphism and hostility. American Journal of Medical Genetics 2004, 127B:28-29.
44. Weinshilboum R.M., Otterness D.M., Szumlanski C.I. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annual Review of Pharmacology and Toxicology 1999, 39:19-52.
45. Wirgenes K.V., Djurovic S., Sundet K., Agartz I., Mattingsdal M., Athanasiu L., Melle I., Andreassen O.A. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophrenia Research 2010, 10.1016/j.schres.2010.05.007.
46. Xie T., Ho S.L., Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Molecular Pharmacology 1999, 56:31-38.
47. Yim D.S., Park S.K., Yoo K.Y., Yoon K.S., Chung H.H., Ahn S.H., Noh D.Y., Choe K.J., Cho S.H., Jang I.J., Shin S.G., Strickland P.T., Hirvonen A., Kang D. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 2001, 11:279-286.